SEC Form 4 · accession 0001315406-17-000020
BIO-RAD LABORATORIES, INC. · BIO BIO.B
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alice N Schwartz
Director · 10% Owner
Period of report
Dec 5, 2017
Accepted (ET)
Dec 28, 2017 · 12:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000012208
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Bio-Rad B Common Stock | Dec 5, 2017 | G | 318 | $0.00 | D | 439,244 | I | By Alice N. Schwartz Revocable Trust |
| Bio-Rad A Common Stock | holding | — | — | — | 1,800,281 | I | By Alice N. Schwartz Revocable Trust | |
| Bio-Rad A Common Stock | holding | — | — | — | 90 | I | By David Schwartz Exemption Trust | |
| Bio-Rad A Common Stock | holding | — | — | — | 240 | I | By David Schwartz Exempt Marital Trust | |
| Bio-Rad A Common Stock | holding | — | — | — | 898,931 | I | By David Schwartz Non-Exempt Marital Trust | |
| Bio-Rad A Common Stock | holding | — | — | — | 34,311 | I | By Charitable Remainder Unitrust | |
| Bio-Rad B Common Stock | holding | — | — | — | 57,000 | I | By David Schwartz Non-Exempt Marital Trust | |
| Bio-Rad B Common StockF1 | holding | — | — | — | 4,060,054 | I | By Blue Raven Partners, L.P. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares are held by a limited partnership of which the reporting person is a general partner.